Viewing StudyNCT00114192



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00114192
Status: COMPLETED
Last Update Posted: 2010-02-01
First Post: 2005-06-13

Brief Title: Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: University of Virginia
Organization: University of Virginia

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
stage IV non-small cell lung cancer View
recurrent non-small cell lung cancer View
stage IIIA non-small cell lung cancer View
stage IIIB non-small cell lung cancer View